Medicare can now cover certain weight loss drugs in a big step for patients
https://www.cnbc.com/2024/03/21/medicare-can-cover-weight-loss-drugs-if-used-for-added-health-benefit.html
Mar 21, 2024 - Medicare patients can soon get coverage for Novo Nordisk's Wegovy as long as it is prescribed to reduce their risk of heart attacks and strokes.
0
U.S. Stocks Pull Back Well Off Best Levels But Closely Mostly Higher
https://www.rttnews.com/story.aspx?Id=3434046
Mar 21, 2024 - Stocks showed a strong move to the upside in early trading on Thursday but gave back ground over the course of the session. While the major averages pulled back well off their best levels of the day, they still ended the session at new record closing highs.
0
U.S. Stocks Seeing Modest Weakness Amid Profit Taking
https://www.rttnews.com/story.aspx?Id=3434271
Mar 22, 2024 - Following the strong upward move seen over the past several sessions, stocks are seeing modest weakness during trading on Friday. Selling pressure has remained relatively subdued, however, limiting the downside for the major averages. In recent trading, the Dow and the S&P 500 have dipped to new lows for the session.
0
Here's how much people are willing to spend on weight loss drugs, according to a new survey
https://www.cnbc.com/2024/03/23/weight-loss-drug-cost-how-much-people-are-willing-to-spend.html
Mar 23, 2024 - Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly correlated to their annual income.
0
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
https://www.cnbc.com/2024/03/27/novo-nordisk-ozempic-can-be-made-for-less-than-5-a-month-study.html
Mar 27, 2024 - Researchers found Novo Nordisk's Ozempic could be manufactured for an estimated 89 cents to $4.73 for a month's supply, figures that include a profit margin.
0
U.S. Stocks Close Little Changed Ahead Of Inflation Data
https://www.rttnews.com/story.aspx?Id=3435701
Mar 28, 2024 - Following the strong upward move seen late in Wednesday's session, stocks showed a lack of direction over the course of the trading day on Thursday. Despite the choppy trading, the Dow and the S&P 500 reached new record closing highs. The major averages eventually ended the session narrowly mixed.
0
U.S. Stocks Lack Direction As Inflation Data Looms
https://www.rttnews.com/story.aspx?Id=3435647
Mar 28, 2024 - Following the strong upward move seen late in the previous session, stocks are showing a lack of direction during trading on Thursday. The major averages have spent the day bouncing back and forth across the unchanged line. Currently, the major averages are slightly higher.
0
Are the restaurant menu items for April Fool's Day still outrageous?
https://www.nrn.com/first-bite/are-restaurant-menu-items-april-fools-day-still-outrageous
Mar 28, 2024 - Ahead of April Fool’s Day, chains have been releasing menu items that may be real. This is a tradition in the restaurant industry where brands promote various menu items that seem outlandish in the hopes that they will drive customers to their stores
0
Everyone is anticipating the California minimum wage law on Monday. Here's what we know.
https://www.nrn.com/first-bite/everyone-anticipating-california-minimum-wage-law-monday-heres-what-we-know
Mar 29, 2024 - California’s controversial $20 minimum wage for quick-service restaurant workers employed by companies with 60 or more locations is set to finally go into effect on Mon. April 1, after undergoing multiple revisions and pushback from the restaurant in
0
Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues
https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?source=feed_sector_healthcare
Mar 30, 2024 - The Health Care Select Sector SPDR Fund ETF (XLV) lagged slightly behind the S&P 500 index in Q1 2024, rising 8.31% compared to the overall market's 10.04%...
0